Wenxia Peng

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).

Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 04, 2026

Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in China.

Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in China.

Journal: EClinicalMedicine

Published: July 31, 2025

Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation.

Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 23, 2025

MYC amplification sensitizes TNBC to CHK1 inhibitors.

MYC amplification sensitizes TNBC to CHK1 inhibitors.

Journal: Cellular signalling

Published: December 09, 2024

Antibody-drug conjugate (disitamab vedotin) therapy targeting HER2-low or higher advanced extramammary Paget's disease.

Antibody-drug conjugate (disitamab vedotin) therapy targeting HER2-low or higher advanced extramammary Paget's disease.

Journal: The oncologist

Published: August 09, 2024

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial.

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial.

Journal: Investigational new drugs

Published: July 27, 2021

Expression of recombinant Schistosoma japonicum protein rSjE16 and its effects on LX-2 cells in vitro.

Expression of recombinant Schistosoma japonicum protein rSjE16 and its effects on LX-2 cells in vitro.

Journal: The Journal of international medical research

Published: December 22, 2020

Nuclear cGAS suppresses DNA repair and promotes tumorigenesis.

Nuclear cGAS suppresses DNA repair and promotes tumorigenesis.

Journal: Nature

Published: August 17, 2017

IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation.

IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation.

Journal: PloS one

Published: October 10, 2016

Recombinant T2 RNase protein of Schistosoma japonicum inhibits expression of α-SMA in LX-2 cells.

Recombinant T2 RNase protein of Schistosoma japonicum inhibits expression of α-SMA in LX-2 cells.

Journal: Parasitology research

Published: January 12, 2016

Schistosoma japonicum protein SjP40 inhibits TGF-β1-induced activation of hepatic stellate cells.

Schistosoma japonicum protein SjP40 inhibits TGF-β1-induced activation of hepatic stellate cells.

Journal: Parasitology research

Published: April 27, 2015

Adenovirus-mediated over-expression of Septin4 ameliorates hepatic fibrosis in mouse livers infected with Schistosoma japonicum.

Adenovirus-mediated over-expression of Septin4 ameliorates hepatic fibrosis in mouse livers infected with Schistosoma japonicum.

Journal: Parasitology international

Published: April 06, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026